What's Going On With Tilray Brands Stock Monday?

Zinger Key Points
  • Tilray says its German cannabis cultivation facility received the first new cannabis cultivation license issued under MedCanG.
  • The license will allow Tilray's German facility to cultivate and manufacture a broad commercial range of medical cannabis.

Tilray Brands Inc TLRY shares are trading higher. The company on Monday announced that its cannabis cultivation facility in Germany received the first new cannabis cultivation license issued under Germany’s new Cannabis Act.

What To Know: Tilray said Aphria RX GmbH received the first new cannabis cultivation license issued under MedCanG. The license will allow Tilray’s German facility to cultivate and manufacture a broad commercial range of medical cannabis.

“We are thrilled to receive this license as it will provide greater access to some of the highest quality medical cannabis produced in Germany and enable us to expand the range of treatment options available to patients,” said Denise Faltischek, chief strategy officer and head of international for Tilray.

“We appreciate the trust that the German Government has placed in Tilray, and we are proud of our team for their groundbreaking work in medical cannabis cultivation and patient care.”

Tilray said it strongly believes these developments will have a positive impact on the health and well-being of many patients in Germany. The company noted that the introduction of the German cannabis bill has led to a significant increase in the number of patients and prescribers for medical cannabis.

Tilray is due to report earnings for the fourth quarter after the market close on July 29.

See Also: Joe Biden Drops Out: What Would Happen With Cannabis Legalization Under Kamala Harris Or Donald Trump?

How To Buy TLRY Stock

By now you're likely curious about how to participate in the market for Tilray – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. In the case of Tilray , which is trading at $1.79 as of publishing time, $100 would buy you 55.87 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

TLRY Price Action: Tilray shares were up 3.35% at $1.85 at the time of publication, according to Benzinga Pro.

Photo: Anan Kaewkhammul/Shutterstock.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsGlobalMoverswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.